Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 10, 2026
TickeronGET DAILY SIGNALS
Braskem (BAK) Q3 2026 Earnings: Watching Petrochemical Spreads and Restructuring Progress

Braskem (BAK) Q3 2026 Earnings: Watching Petrochemical Spreads and Restructuring Progress

Key Takeaways

  • Braskem S.A. (BAK) is expected to report its third-quarter 2026 results around November 11–12, 2026, after the market close.
  • Analyst consensus points to roughly $0.02 in earnings per share (EPS) on about $3.64 billion in revenue, a double-digit top-line gain from the prior-year quarter.
  • The quarter arrives as management has warned that the strong second-quarter lift was "tactical, not structural," with petrochemical spreads normalizing.
  • Investors are focused on recurring EBITDA, plant utilization rates, and progress on Braskem's capital-structure restructuring with creditors.
  • Weak global polyethylene supply-demand balance and high leverage remain the central risks to the investment case.
  • For deeper context on this ticker, you can review Major News, Today's Price Move, Price Targets, and Forecast on Tickeron's dedicated pages.
  • To see how automated strategies are positioning around earnings season, explore Tickeron's Trending AI Robots.

Why Braskem's Results Carry Weight

Braskem S.A. (BAK) ranks among the largest producers of thermoplastic resins including polyethylene, polypropylene, and PVC, with operations spanning Brazil, the United States, Europe, and Mexico. Profitability depends heavily on the spread between resin prices and feedstock costs, so each quarterly release offers a direct window into the global petrochemical cycle. The company continues to manage a prolonged industry downturn driven by overcapacity while also addressing its capital structure and elevated leverage. In my view, the upcoming print will matter most for signals on cost discipline, demand trends in Brazil, and whether restructuring efforts can ease balance-sheet pressure that has weighed on the ADR.

Consensus Estimates and What to Watch

MarketBeat consensus calls for third-quarter 2026 EPS of about $0.02 and revenue near $3.64 billion, marking a double-digit increase from roughly $3.17 billion in the year-ago quarter. Other aggregators show somewhat higher per-share figures, reflecting dispersion among the limited analyst coverage. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Recurring EBITDA will draw close attention after the second-quarter 2026 figure reached approximately $1.04 billion on a temporary Brazil-segment boost tied to Middle East supply issues. Management has already noted those gains were tactical rather than structural, so investors will track utilization rates across regions, resin volumes, and any fresh updates on debt negotiations.

Market Sentiment Heading Into the Report

Caution prevails as shares have faced pressure from weak global polyethylene demand, ongoing overcapacity, and restructuring uncertainty. Some trackers show a negative post-earnings drift after the August 2026 release, suggesting the market has been quick to temper near-term optimism. Main risks include further spread compression, softer Brazilian resin demand, and possible dilution from restructuring. On the positive side, operational gains in Mexico and tighter cost control could support a steadier tone.

Key Factors to Follow After the Print

The path of petrochemical spreads will dominate the outlook, with management already highlighting an oversupplied polyethylene market. Any renewed pressure on resin prices versus naphtha or ethane costs would weigh on margins through year-end. Operationally, utilization rates and the ethane supply ramp in Mexico via Braskem Idesa deserve attention, as does domestic resin demand and the green polyethylene segment in Brazil. Capital-structure developments—bank and bondholder talks, out-of-court terms, and dilution risks—will likely influence the stock more than a single quarter’s EBITDA. Updates on the long-term ethane agreement with Petrobras and the broader transformation program will also help assess whether cyclical relief can translate into lasting recovery.

Exploring Tickeron’s AI Tools in My Research

I’ve found Tickeron’s AI Daily Buy/Sell Signals helpful for gauging momentum around earnings events like this one. The platform lets me review automated signals and historical patterns quickly, which adds useful context when comparing BAK to peers in the materials sector. It’s become a regular part of how I cross-check ideas without replacing my own fundamental work.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BAK

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Momentum Indicator for BAK turns positive, indicating new upward trend

BAK saw its Momentum Indicator move above the 0 level on November 09, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 78 similar instances where the indicator turned positive. In 62 of the 78 cases, the stock moved higher in the following days. The odds of a move higher are at 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BAK's RSI Indicator exited the oversold zone, 36 of 51 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 57 of 75 cases where BAK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.

Following a +5.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where BAK advanced for three days, in 187 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

BAK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for BAK turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 36 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.

BAK moved below its 50-day moving average on October 15, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BAK's P/B Ratio (-0.035) is slightly lower than the industry average of (1.147). P/E Ratio (-0.078) is within average values for comparable stocks, (3.243). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (3.769). BAK's Dividend Yield (2.475) is considerably higher than the industry average of (0.195). P/S Ratio (0.051) is also within normal values, averaging (0.578).

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. BAK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BAK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

Notable companies

The most notable companies in this group are Dow (NYSE:DOW).

Industry description

The major diversified chemicals industry includes companies that produce a wide range of chemicals and industrial gases. The products are often used as raw materials in the manufacturing of various types of goods, including plastics, paints, carpets, and fixtures to name a few. Major companies making diversified chemicals include DuPont de Nemours Inc., Celanese Corporation, Celanese Corporation and Westlake Chemical Corporation.

Market Cap

The average market capitalization across the Chemicals: Major Diversified Industry is 2.83B. The market cap for tickers in the group ranges from 80.4K to 67.31B. SHECF holds the highest valuation in this group at 67.31B. The lowest valued company is DEVV at 80.4K.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Major Diversified Industry was -2%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was -25%. VHI experienced the highest price growth at 10%, while TROX experienced the biggest fall at -22%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Major Diversified Industry was -13%. For the same stocks of the Industry, the average monthly volume growth was 3% and the average quarterly volume growth was -19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 52
Price Growth Rating: 58
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: 17 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of petrochemicals and other related products

Industry ChemicalsMajorDiversified

Industry
Chemicals Specialty
Address
Rua Lemos Monteiro
Phone
+55 1135769531
Employees
8233
Web
https://www.braskem.com.br
Interact to see
Advertisement
AtlasClear Holdings (ATCH) shares fell roughly 25.5% over the last 30 days, declining from $0.1881 on October 2 to $0.1401 on October 30. The pullback extended a longer downtrend that has kept the stock trading well below the $1.00 NYSE American minimum, keeping continued listing-compliance risk in focus.
XRPN fell -9.70% in early regular-session trading on Tuesday, sliding from Monday's $10.41 close to $9.40. The decline follows a November 9 SEC prospectus disclosing a committed equity facility with Cantor to sell up to 5.2 million new Class A shares at 97% of the volume-weighted average price, implying up to roughly 16.7% potential dilution.
The $1.50 central target is a fallback objective drawn from public market and technical discussion, not an analyst consensus, because AquaBounty Technologies, Inc. (NASDAQ: AQB) has no credible, current sell-side price targets. With the stock near $0.95, reaching $1.50 would require roughly 58% upside, a very large move for a company that has wound down its core aquaculture operations.
The central target of $1,620 is the arithmetic mean of verified, current analyst price targets, rounded to a clean level; it is not a single firm's forecast or a guarantee. At a recent price of about $690 , reaching $1,620 would require a gain of roughly 135% , a very large move by any standard.
NVDA dropped from Friday's close of $186.64 to $174.06 intraday, down -6.74%, during regular market hours. The slide followed CEO Jensen Huang's admission of an extramarital affair and the board's independent investigation, announced November 8, after reports he was targeted by a suspected Chinese intelligence operative.